Clinical trial
Rapid Diagnostic Test for COVID-19 Based on Antibody Detection
NCT04490837 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rapid Diagnostic Test for COVID-19 Based on Antibody Detection
- Lead sponsor
- Corporacion Parc Tauli
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 22, 2020
- Completion date
- September 30, 2020
- Enrollment
- 3,500 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.